Kotak Pioneer Fund- Regular Plan- Growth Option
💡 Why Pick This Fund? Quantitative Strengths & Watch-outs
- Outperformed category benchmark in 88% of historical 3-year rolling periods.
- Strong capital defense: downside capture of 77% limits losses during market corrections.
- Generated +6.7% annualized alpha (excess return) over its benchmark.
- Cost-efficient: expense ratio of 1.9% is lower than category median (2.52%).
- Experienced a maximum drawdown of -35.9% during severe market crashes.
Key Statistics vs Category Median
Trailing Returns Comparison
| Period | Fund Return | Category Median | Difference |
|---|---|---|---|
| 1 Month | +1.38% | +6.32% | -4.94% |
| 3 Months | -1.24% | -0.20% | -1.04% |
| 6 Months | +7.31% | +5.98% | +1.33% |
| 1 Year | +9.19% | +3.90% | +5.29% |
| 3 Years CAGR | +18.33% | +13.23% | +5.10% |
| 5 Years CAGR | +12.80% | +10.72% | +2.08% |
| 7 Years CAGR | +19.68% | +15.35% | +4.33% |
| Since Inception | +19.67% | - | - |
📈 Monthly SIP vs Bank Fixed Deposit (FD) Replay
See how a regular monthly SIP in Kotak Pioneer Fund compares against a standard 7.0% p.a. Bank Fixed Deposit.
Calendar Year Returns
| Year | Fund | Category Median | Gap |
|---|---|---|---|
| 2026 | +10.15% | +4.03% | +6.12% |
| 2025 | +6.23% | +1.43% | +4.80% |
| 2024 | +28.57% | +20.41% | +8.16% |
| 2023 | +36.67% | +30.70% | +5.97% |
| 2022 | -8.36% | +1.66% | -10.02% |
| 2021 | +36.11% | +30.31% | +5.80% |
| 2020 | +33.09% | +13.54% | +19.55% |
Daily Rolling Returns Summary
| Rolling Window | Minimum | Average | Median | Maximum | % Positive | % Beating Proxy |
|---|---|---|---|---|---|---|
| 1-Year Rolling | -13.13% | +24.11% | +16.25% | +125.44% | 89.4% | 76.9% |
| 3-Year Rolling | +12.40% | +20.71% | +20.12% | +36.33% | 100.0% | 88.5% |
| 5-Year Rolling | +11.68% | +20.23% | +21.32% | +32.21% | 100.0% | 100.0% |
Risk Profile & Deepest Drawdowns
Deepest Market Corrections (Depth >= 10%)
| Peak Date | Trough Date | Fall Depth | Months to Bottom | Recovery Period |
|---|---|---|---|---|
| 2020-01-17 | 2020-03-23 | -35.9% | 2 months | 4 months |
| 2021-11-16 | 2022-06-20 | -22.5% | 7 months | 12 months |
| 2024-09-27 | 2025-04-07 | -19.9% | 6 months | 4 months |
Portfolio & Asset Allocation
Statutory Asset Allocation Mandate (SEBI / SID)
| Instrument Category | Permitted Allocation Range |
|---|---|
| Equity and Equity Related Instruments of companies having pioneering innovations theme 80%-100% Equity and Equity Related Instruments of companies other than having pioneering innovations theme | 0%- 20% Debt and Money Market Instruments- 0%-20% Units of Gold/Silver ETF- 0%-20% Units of InvITs- 0-10%" |
Investment Objective & Strategy
The investment objective of the scheme is to generate capital appreciation from a diversified portfolio of equity, equity related instruments and units of global mutual funds which invests into such companies that utilize new forms of production, technology, distribution or processes which are likely to challenge existing markets or value networks, or displace established market leaders, or bring in novel products and/or business models. However, there is no assurance that the objective of the scheme will be achieved.
ℹ️ Detailed monthly stock-level holdings for this scheme are updated periodically from asset management company statutory disclosures.
Fund Size Position
Currently managing Rs 4,405 cr (AMFI Daily Fund AUM as of 2026-11-09). Positioned as stretched relative to Sectoral / Thematic schemes.
Fund Management
Cost & Capital Gains Taxation
From April 2026 the total expense ratio includes brokerage, transaction costs and statutory levies on top of the base fee.
Equity-oriented schemes: 20% short-term capital gains tax if sold within 12 months; 12.5% long-term capital gains tax on gains exceeding ₹1.25 lakh per financial year when held for more than 12 months.
Closest Sectoral / Thematic Peers by Rank
| Scheme | Score | 3Y Return | Expense | Downside | Fund Size | Compare |
|---|---|---|---|---|---|---|
| LIC MF Healthcare Fund | 7.1 | +20.28% | 2.72% | 59.8% | Rs 101 cr | Compare → |
| Aditya Birla Sun Life Special Opportunities Fund | 7.1 | +18.81% | 2.26% | 78.6% | Rs 1,475 cr | Compare → |
| Aditya Birla Sun Life Pharma and Healthcare Fund | 7.4 | +19.30% | 2.27% | 50.0% | Rs 1,154 cr | Compare → |
| ITI Pharma and Healthcare Fund | 6.6 | +18.46% | 2.57% | 71.7% | Rs 283 cr | Compare → |
| Aditya Birla Sun Life International Equity Fund | 5.8 | +20.53% | 2.55% | -28.3% | Rs 337 cr | Compare → |
Frequently Asked Questions about Kotak Pioneer Fund
What is the expense ratio of Kotak Pioneer Fund?
Kotak Pioneer Fund has a total expense ratio (TER) of 1.9% with a base expense ratio of 1.57%, compared to the Sectoral / Thematic category median of 2.52%.
Who manages Kotak Pioneer Fund?
Kotak Pioneer Fund is managed by Shibani Kurian.
What are the historical returns of Kotak Pioneer Fund?
Kotak Pioneer Fund delivered a 3-year CAGR of 18.33% and a 5-year CAGR of 12.8%. Its 1-year return stands at +9.19%.
How large is Kotak Pioneer Fund?
Kotak Pioneer Fund manages assets of Rs 4,405 cr, placing it in the 'stretched' size band relative to Sectoral / Thematic peers.
How is Kotak Pioneer Fund scored on MFIQ?
Kotak Pioneer Fund holds an MFIQ Score of 7.3/10 (Good), based on a category percentile composite across returns, risk, consistency, and cost.
How risky is Kotak Pioneer Fund?
Kotak Pioneer Fund has an official SEBI riskometer rating of Very High. Over the analyzed period, its annualized standard deviation is 13.12% with a maximum historical drawdown of -35.91%.